Healthcare provider profile · identity verified

Connor Hayes Harmann, MD

Family Practice · SHEBOYGAN, WI · NPI 1043772486

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	770	220
Losartan Potassium	Losartan Potassium	464	131
Amlodipine Besylate	Amlodipine Besylate	380	106
Lisinopril	Lisinopril	361	105
Levothyroxine Sodium	Levothyroxine Sodium	316	88
Metoprolol Succinate	Metoprolol Succinate	313	88
Metformin Hcl	Metformin Hcl	301	87
Simvastatin	Simvastatin	285	92
Omeprazole	Omeprazole	256	79
Pantoprazole Sodium	Pantoprazole Sodium	247	73
Hydrochlorothiazide	Hydrochlorothiazide	228	66
Metformin Hcl Er	Metformin Hcl	210	62
Gabapentin	Gabapentin	205	63
Rosuvastatin Calcium	Rosuvastatin Calcium	204	60
Furosemide	Furosemide	198	48
Tamsulosin Hcl	Tamsulosin Hcl	181	54
Allopurinol	Allopurinol	175	46
Sertraline Hcl	Sertraline Hcl	165	38
Trazodone Hcl	Trazodone Hcl	149	37
Clopidogrel	Clopidogrel Bisulfate	123	29
Metoprolol Tartrate	Metoprolol Tartrate	115	38
Albuterol Sulfate Hfa	Albuterol Sulfate	109	38
Alprazolam	Alprazolam	104	27
Potassium Chloride	Potassium Chloride	103	30
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	97	24
Pravastatin Sodium	Pravastatin Sodium	95	30
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	91	14
Tramadol Hcl	Tramadol Hcl	89	26
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	88	27
Montelukast Sodium	Montelukast Sodium	86	23
Jardiance	Empagliflozin	85	19
Glipizide Er	Glipizide	84	23
Zolpidem Tartrate	Zolpidem Tartrate	83	23
Eliquis	Apixaban	81	21
Duloxetine Hcl	Duloxetine Hcl	76	21
Spironolactone	Spironolactone	76	21
Meloxicam	Meloxicam	75	28
Pregabalin	Pregabalin	69	11
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	66	23
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	63	22
Tizanidine Hcl	Tizanidine Hcl	63	22
Lovastatin	Lovastatin	62	20
Alendronate Sodium	Alendronate Sodium	61	22
Citalopram Hbr	Citalopram Hydrobromide	59	17
Fluticasone Propionate	Fluticasone Propionate	59	24
Donepezil Hcl	Donepezil Hcl	58	12
Prednisone	Prednisone	58	21
Famotidine	Famotidine	56	15
Atenolol	Atenolol	55	19
Paroxetine Hcl	Paroxetine Hcl	50	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	48	23
Clonazepam	Clonazepam	47	suppressed
Ozempic	Semaglutide	47	11
Bupropion Xl	Bupropion Hcl	46	13
Carvedilol	Carvedilol	45	12
Glipizide	Glipizide	45	12
Ezetimibe	Ezetimibe	41	suppressed
Lorazepam	Lorazepam	40	13
Finasteride	Finasteride	39	16
Doxazosin Mesylate	Doxazosin Mesylate	38	13
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	38	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	37	suppressed
Breo Ellipta	Fluticasone/Vilanterol	35	suppressed
Glimepiride	Glimepiride	35	11
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	34	11
Esomeprazole Magnesium	Esomeprazole Magnesium	32	12
Midodrine Hcl	Midodrine Hcl	32	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	32	13
Chlorthalidone	Chlorthalidone	31	suppressed
Januvia	Sitagliptin Phosphate	31	suppressed
Propranolol Hcl	Propranolol Hcl	31	suppressed
Ropinirole Hcl	Ropinirole Hcl	31	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	30	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	29	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	29	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	27	suppressed
Terazosin Hcl	Terazosin Hcl	27	suppressed
Clonidine Hcl	Clonidine Hcl	26	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	26	13
Hydralazine Hcl	Hydralazine Hcl	26	suppressed
Propranolol Hcl Er	Propranolol Hcl	26	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	26	20
Xarelto	Rivaroxaban	26	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	25	suppressed
Fluconazole	Fluconazole	25	15
Escitalopram Oxalate	Escitalopram Oxalate	24	suppressed
Levetiracetam	Levetiracetam	24	suppressed
Mirtazapine	Mirtazapine	23	suppressed
Verapamil Er	Verapamil Hcl	23	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	23	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	22	19
Memantine Hcl	Memantine Hcl	22	suppressed
Meclizine Hcl	Meclizine Hcl	21	suppressed
Mounjaro	Tirzepatide	21	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	20	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	20	suppressed
Torsemide	Torsemide	20	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	19	suppressed
Buspirone Hcl	Buspirone Hcl	19	suppressed
Nabumetone	Nabumetone	18	suppressed
Symbicort	Budesonide/Formoterol Fumarate	18	suppressed
Warfarin Sodium	Warfarin Sodium	18	suppressed
Digoxin	Digoxin	17	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	17	suppressed
Ketoconazole	Ketoconazole	17	suppressed
Nystatin	Nystatin	17	11
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	17	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	16	suppressed
Baclofen	Baclofen	16	suppressed
Colestipol Hcl	Colestipol Hcl	16	suppressed
Ondansetron Odt	Ondansetron	16	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	16	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	16	suppressed
Topiramate	Topiramate	16	suppressed
Trulicity	Dulaglutide	16	suppressed
Benazepril Hcl	Benazepril Hcl	15	suppressed
Cephalexin	Cephalexin	15	suppressed
Irbesartan	Irbesartan	15	suppressed
Oxycodone Hcl	Oxycodone Hcl	15	suppressed
Solifenacin Succinate	Solifenacin Succinate	15	suppressed
Spiriva Handihaler	Tiotropium Bromide	15	suppressed
Tradjenta	Linagliptin	15	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	14	suppressed
Fenofibrate	Fenofibrate	14	suppressed
Humalog Kwikpen U-100	Insulin Lispro	14	suppressed
Latanoprost	Latanoprost	14	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	14	suppressed
Ventolin Hfa	Albuterol Sulfate	14	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	13	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	13	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	13	suppressed
Ibuprofen	Ibuprofen	13	suppressed
Nifedipine Er	Nifedipine	13	suppressed
Novolog Flexpen	Insulin Aspart	13	suppressed
Novolog Mix 70-30 Flexpen	Insulin Aspart Prot/Insuln Asp	13	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	13	13
Sucralfate	Sucralfate	13	suppressed
Temazepam	Temazepam	13	suppressed
Enalapril Maleate	Enalapril Maleate	12	suppressed
Lamotrigine	Lamotrigine	12	suppressed
Loperamide	Loperamide Hcl	12	suppressed
Pyridostigmine Bromide	Pyridostigmine Bromide	12	suppressed
Rybelsus	Semaglutide	12	suppressed
Synthroid	Levothyroxine Sodium	12	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	12	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	12	suppressed
Humalog Mix 75-25 Kwikpen	Insulin Lispro Protamin/Lispro	11	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	11	suppressed
Valacyclovir	Valacyclovir Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error